Answers are grounded in this paper and cite their sources.
Real-world outcomes reveal surgical decisions in BRCA VUS carriers vary widely, suggesting an urgent need for better genetic counseling.
While pathogenic BRCA1/2 variants are strongly associated with bilateral mastectomy in breast cancer patients, surgical decision-making among VUS carriers appears largely independent of tumor biology or genetic subtype and is primarily influenced by age. These findings highlight substantial heterogeneity and potential overtreatment in the management of BRCA VUS carriers, underscoring the need for improved genetic counseling and standardized approaches to mitigate the impact of genetic uncertainty on clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Ökten et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: